Abstract
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.
Cite
CITATION STYLE
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., … Hughes, M. (2022). Non-Small Cell Lung Cancer, Version 3.2022. JNCCN Journal of the National Comprehensive Cancer Network, 20(5), 497–530. https://doi.org/10.6004/jnccn.2022.0025
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
